Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1002)	12/16/1997 12:13:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 7041

Bill <<What also intrigues me (besides the fact that Vasomax is ineffective for erectile dysfunction...if not an outright fraud), is the fact that the company is very undercapitalized if it intends to go through the entire FDA approval process.>> Bill: Under their agreement with Zonagen, Schering is responsible for taking Vasomax through the NDA process. BigKNY3

To: Bill Wexler who wrote (1002)	12/16/1997 7:07:00 PM
From: Claud B	Read Replies (1) \| Respond to of 7041

You have your Schering's totally confused, my friend. Schering AG is the company that put seed money into the company and Schering Plough is the company that recently made the marketing deal with Zonagen. NO CONNECTION!! Furthermore, as far as being undercapitalized if it intends to go through the entire FDA approval process....you're wrong again. Schering Plough in it's marketing agreement will carry the ball through that process, not Zonagen. Schering Plough, last time I looked, didn't appear to me to be undercapitalized for this procedure. Always helps to have the facts before you leap. Claud